Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study
about
Role of diabetes in heart rhythm disordersDiagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia?What do we currently know about metabolic syndrome and atrial fibrillation?Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitusEffect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial.Low fasting plasma insulin is associated atrial fibrillation in men from a cohort study--the Malmö preventive projectClinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.Type 2 diabetes mellitus and risk of incident atrial fibrillation in women.Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation.Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression.Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysisObesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Calpain-Calcineurin-Nuclear Factor Signaling and the Development of Atrial Fibrillation in Patients with Valvular Heart Disease and DiabetesIncidence, Risk Factors and Outcomes of New Onset Supraventricular Arrhythmias in African American Patients with Severe SepsisNovel genetic markers improve measures of atrial fibrillation risk prediction.Postoperative Atrial Fibrillation: Year 2011 Review of Predictive and Preventative Factors of Atrial Fibrillation Post Cardiac SurgeryDiabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and InterventionsThe diagnosis and management of cerebrovascular disease in diabetes.Almanac 2013: cardiac arrhythmias and pacing.Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies.High risk factors of atrial fibrillation in type 2 diabetes: results from the Chinese Kailuan study.Is diabetes a hypercoagulable state? A critical appraisal.Management and prognosis of atrial fibrillation in the diabetic patient.The role of obesity in atrial fibrillation.Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus.Atrial fibrillation and diabetes mellitus. Correlation, co-existence, and coagulation therapy.Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).Effect of Selenium on Stress Response in Coronary Artery Bypass Graft Surgery: A Clinical Trial.[Diabetes, prediabetes and cardiovascular risk].Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Association between glycosylated hemoglobin and intentional weight loss in overweight and obese patients with type 2 diabetes mellitus: a retrospective cohort study.The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial).European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm SocieAntihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients.A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study.Diabetes mellitus and atrial remodelling in patients with paroxysmal atrial fibrillation: Role of electroanatomical mapping and catheter ablation.
P2860
Q26767099-A7D46764-669B-4C15-B53B-656316C87730Q26800991-72859972-E659-4081-948C-C57373A8D0D7Q26864437-663CFE0E-19AE-4566-B3BB-2BE1BAED8A77Q27014826-96D0845A-206C-4E6D-A9C7-7FF8519A54EDQ27334353-FEA0E64A-DFFD-44C3-9E99-6BDB35C90AB7Q34537843-450555CF-877A-410C-8F88-08B963BD5FE5Q34774249-D9772DAF-6677-4EF3-97D6-E1C6584779BDQ34779355-3DFD3272-CDB3-4802-962C-95CE16E31A83Q34921180-C524048A-44F9-459B-976B-8C6237DF06A6Q35021968-D7114A08-7F1E-45DC-B522-35DF3BB215F3Q36299330-FFC8F967-35E5-4CE7-AF47-EEDD0FCFF2B6Q36337187-7356B260-76FC-4371-A862-758CAC36CD67Q36382360-A6BC44CF-01D1-4EB2-9E2B-91CD98D3DEB2Q36795482-75DACA71-A704-48D2-B490-B139D04E98B8Q36813317-CC559588-2280-4E51-8CFA-60D983F52479Q37061256-33F604C6-5C5B-4651-A3E5-985425C09F52Q37496275-ADED1900-B068-4B1C-8FFD-1C63ABB1B659Q37496314-3101D121-B4A4-4725-8D03-2DE8C633F62CQ38001593-EEA872FA-D9E0-4633-8ED5-F813FE040170Q38125860-C4121C2E-69CE-424B-ACE9-3FF7B6A83E66Q38234313-903142EF-E408-49D0-8E6F-D84F1ECE9259Q38365003-7215A198-3365-4E2B-BCC4-24A2418CBF2EQ38409740-92C105E2-7936-42C4-8512-0E189BCD097DQ38497702-D0BD110D-760C-4AF4-B61B-285F5FA4E2A7Q38586946-B13F970A-AC09-4715-9C5E-78C1B06FC547Q39409421-35E5796F-A939-4D89-91ED-F1A9B766C95AQ39635843-D82F2D85-6621-4B17-A6D0-6D7A39D36E31Q40421283-CE90B235-6F9F-4793-9852-31368A18AFBBQ40611571-E5988739-6163-46D3-B6BA-6CB25C027CB2Q41369770-C102CED8-E96F-498C-A94F-F88FCF774E52Q41721838-68CFA887-C68B-43BA-89E1-E62F3E9BC8C3Q42368137-ACAC2C68-1197-42DE-AB99-2E2FA92F3D17Q45059153-9A7DCFAD-7765-4D59-9DBE-531B60A6CA62Q46658026-82CAACD6-78F1-4154-825E-A1160A7BA38CQ47315473-77A0441F-AE57-41C9-AD39-E3DB06DE874EQ47779331-8721E499-E35D-40C7-8728-60ED3EBFA871Q47796802-8AC83674-BB1E-48AD-A9DC-D3AE520930A9Q47927131-106AD75A-B3D2-44F4-A3F5-9A65B2716B5AQ48133777-41E1B57C-A368-4C9F-B2FE-A6F0B0F0F7A5Q48233660-FB062B45-AD36-4644-A048-41B0828406CC
P2860
Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Type 2 diabetes, glucose homeo ...... osis Risk in Communities study
@ast
Type 2 diabetes, glucose homeo ...... osis Risk in Communities study
@en
type
label
Type 2 diabetes, glucose homeo ...... osis Risk in Communities study
@ast
Type 2 diabetes, glucose homeo ...... osis Risk in Communities study
@en
prefLabel
Type 2 diabetes, glucose homeo ...... osis Risk in Communities study
@ast
Type 2 diabetes, glucose homeo ...... osis Risk in Communities study
@en
P2093
P2860
P50
P921
P1433
P1476
Type 2 diabetes, glucose homeo ...... osis Risk in Communities study
@en
P2093
Elsayed Z Soliman
Faye L Lopez
Laura R Loehr
Rachel R Huxley
Sunil K Agarwal
P2860
P304
P356
10.1136/HEARTJNL-2011-300503
P407
P577
2011-09-19T00:00:00Z